Olanzapine Tablet, Orally Disintegrating
Product Images NDC 65862-656

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 65862-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (5 mg Blister Carton (3 x 10 Tablets))

Package Label-principal Display Panel (5 mg Blister Carton (3 x 10 Tablets))
This is a description for a medication called Olanzapine Orally Disintegrating Tablets USP 5mg. The tablets come in a 30-pack unit-dose and each tablet contains 5mg of Otanzpine USP. Phenyketonurics should note that the tablets contain phenyanine in the amount of 028 g per bt. The tablets should be stored at a temperature ranging from 3120°1025°C (68°to 77°F). Users should not open a blister until immediately prior to use. The medication is not resistant to moisture, so an acid-resistant container should be used in outpatient settings. A dispensation guide is available for the pharmacist to distribute to each patient.*
FDA Label Image

Package Label-principal Display Panel (10 mg Blister Carton (3 x 10 Tablets))

Package Label-principal Display Panel (10 mg Blister Carton (3 x 10 Tablets))
This is a package of Olanzapine Orally Disintegrating Tablets USP, containing 30 unit-dose tablets of 10mg each. The tablets are advised to be stored at a temperature between 3120°1025°C (68°to 77°F). The medication guide should be dispensed by the pharmacist to each patient. However, no information is provided on the uses and its therapeutic category.*
FDA Label Image

Package Label-principal Display Panel (15 mg Blister Carton (3 x 10 Tablets))

Package Label-principal Display Panel (15 mg Blister Carton (3 x 10 Tablets))
Olanzapine Orally Disintegrating Tablets USP, containing 15mg of Olanzapine USP in each tablet, with a warning for Phenylketonurics, who must take care as the tablets contain phenylalanine. Dosage instructions can be found in the accompanying literature. Store between 20-25°C (66-77 °F). The unit-dose package is not child-resistant, so a suitable container must be used. The package contains 30 (3 x 10) unit-dose tablets, with the NDC number 65862-658-03. A medication guide should be provided to each patient. Made in India and distributed by Aurobindo, with a code of TS/DRUGS/22/2009. Printing is not allowed on the dotted lines.*
FDA Label Image

Package Label-principal Display Panel (20 mg Blister Carton (3 x 10 Tablets))

Package Label-principal Display Panel (20 mg Blister Carton (3 x 10 Tablets))
This is a description for Olanzapine Orally Disintegrating Tablets. Each tablet contains 20mg of Olanzapine USP, and caution is advised for phenylketonurics as it contains phenyalanine 1.12mg per tablet. Dosage information can be found in the information accompanying the tablets. The tablets should be stored at 20° to 25°C (66° to 77°F), and should not be opened until immediately prior to use. The package is not child resistant, so a child-resistant container should be used for outpatient use. This package contains 30 (3 x 10) unit-dose tablets. The medication guide should be dispensed to each patient by the pharmacist. The tablets are distributed by Aurobindo and Made in India.*
FDA Label Image

Chemical Structure (Olanzapine Str)

Chemical Structure (Olanzapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.